Sahajanand Medical Technologies IPO
Live Updates, GMP, Subscription Data, and Financial Details
IPO Overview
Listed
Dates
Oct 15 to Oct 19 2026
Price Band
₹327 - 344
Current GMP
₹371.15 (+7.89%)
Subscription
14.21 times
IPO Details
| IPO Date | 15 to 19 Oct, 2026 |
| Listed on | Fri, Oct 23, 2026 |
| Face Value | ₹ 1 per share |
| Price Band | ₹327 to ₹344 |
| Issue Price | ₹344 per share |
| Lot Size | 43 Shares |
| Sale Type | OFS only |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE, NSE |
| Total Issue Size | 1,38,22,116 shares (agg. up to ₹ 475 Cr) |
| Offer for Sale | 1,38,22,116 shares of ₹ 1 (agg. up to ₹ 475 Cr) |
| Share Holding Pre Issue | 10,16,46,778 shares |
| Share Holding Post Issue | 10,16,46,778 shares |
| BSE Script Code / NSE Symbol | 545001 / SMT |
| ISIN | INE356Y01018 |
IPO Date
15 to 19 Oct, 2026
Listed on
Fri, Oct 23, 2026
Face Value
₹ 1 per share
Price Band
₹327 to ₹344
Issue Price
₹344 per share
Lot Size
43 Shares
Sale Type
OFS only
Issue Type
Bookbuilding IPO
Listing At
BSE, NSE
Total Issue Size
1,38,22,116 shares (agg. up to ₹ 475 Cr)
Offer for Sale
1,38,22,116 shares of ₹ 1 (agg. up to ₹ 475 Cr)
Share Holding Pre Issue
10,16,46,778 shares
Share Holding Post Issue
10,16,46,778 shares
BSE Script Code / NSE Symbol
545001 / SMT
ISIN
INE356Y01018
IPO Subscription Details
| Anchor | 1 |
| QIB (Ex Anchor) | 34.70 |
| NII | 14.64 |
| bNII (> ₹10L) | 16.37 |
| sNII (< ₹10L) | 11.19 |
| Retail | 3.04 |
| Employees | 0.37 |
| Total ** | 14.21 |
Anchor
1
QIB (Ex Anchor)
34.70
NII
14.64
bNII (> ₹10L)
16.37
sNII (< ₹10L)
11.19
Retail
3.04
Employees
0.37
Total **
14.21
Day Wise Sub
| Day | QIB (Ex Anchor) | NII | NII (> ₹10L) | NII (< ₹10L) | Retail | EMP | Total |
|---|---|---|---|---|---|---|---|
| Oct 1 5 (Day 1) | 0.37 | 0.20 | 0.13 | 0.36 | 0.41 | 0.08 | 0.35 |
| Oct 1 6 (Day 2) | 1.12 | 0.51 | 0.38 | 0.77 | 0.83 | 0.14 | 0.83 |
| Oct 1 9 (Day 3) | 34.70 | 14.64 | 16.37 | 11.19 | 3.04 | 0.37 | 14.21 |
DayOct 1
5 (Day 1)
QIB (Ex Anchor)0.37
NII0.20
NII (> ₹10L)0.13
NII (< ₹10L)0.36
Retail0.41
EMP0.08
Total0.35
DayOct 1
6 (Day 2)
QIB (Ex Anchor)1.12
NII0.51
NII (> ₹10L)0.38
NII (< ₹10L)0.77
Retail0.83
EMP0.14
Total0.83
DayOct 1
9 (Day 3)
QIB (Ex Anchor)34.70
NII14.64
NII (> ₹10L)16.37
NII (< ₹10L)11.19
Retail3.04
EMP0.37
Total14.21
Day Wise GMP
| GMP Date | IPO Price | GMP | Est. Listing Price |
|---|---|---|---|
| 23-10-2026 | 344 | 17 (4.94%) | 361 |
| 22-10-2026 | 344 | 17 (4.94%) | 361 |
| 21-10-2026 | 344 | 19 (5.52%) | 363 |
| 20-10-2026 | 344 | 24 (6.98%) | 368 |
| 19-10-2026 | 344 | 24 (6.98%) | 368 |
| 18-10-2026 | 344 | 25 (7.27%) | 369 |
| 17-10-2026 | 344 | 15 (4.36%) | 359 |
| 16-10-2026 | 344 | 35 (10.17%) | 379 |
| 15-10-2026 | 344 | 43 (12.50%) | 387 |
| 14-10-2026 | 344 | 41 (11.92%) | 385 |
| 13-10-2026 | 344 | 41 (11.92%) | 385 |
| 12-10-2026 | 344 | 35 (10.17%) | 379 |
| 11-10-2026 | 0 | 40 (0%) | 40 |
GMP Date23-10-2026
IPO Price344
GMP17 (4.94%)
Est. Listing Price361
GMP Date22-10-2026
IPO Price344
GMP17 (4.94%)
Est. Listing Price361
GMP Date21-10-2026
IPO Price344
GMP19 (5.52%)
Est. Listing Price363
GMP Date20-10-2026
IPO Price344
GMP24 (6.98%)
Est. Listing Price368
GMP Date19-10-2026
IPO Price344
GMP24 (6.98%)
Est. Listing Price368
GMP Date18-10-2026
IPO Price344
GMP25 (7.27%)
Est. Listing Price369
GMP Date17-10-2026
IPO Price344
GMP15 (4.36%)
Est. Listing Price359
GMP Date16-10-2026
IPO Price344
GMP35 (10.17%)
Est. Listing Price379
GMP Date15-10-2026
IPO Price344
GMP43 (12.50%)
Est. Listing Price387
GMP Date14-10-2026
IPO Price344
GMP41 (11.92%)
Est. Listing Price385
GMP Date13-10-2026
IPO Price344
GMP41 (11.92%)
Est. Listing Price385
GMP Date12-10-2026
IPO Price344
GMP35 (10.17%)
Est. Listing Price379
GMP Date11-10-2026
IPO Price0
GMP40 (0%)
Est. Listing Price40
IPO Important Dates
| IPO Open | Thu, Oct 15, 2026 |
| IPO Close | Mon, Oct 19, 2026 |
| Allotment | Wed, Oct 21, 2026 |
| Refund | Thu, Oct 22, 2026 |
| Credit of Shares | Thu, Oct 22, 2026 |
| Listing | Fri, Oct 23, 2026 |
IPO Open
Thu, Oct 15, 2026
IPO Close
Mon, Oct 19, 2026
Allotment
Wed, Oct 21, 2026
Refund
Thu, Oct 22, 2026
Credit of Shares
Thu, Oct 22, 2026
Listing
Fri, Oct 23, 2026
IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 43 | ₹14,792 |
| Retail (Max) | 13 | 559 | ₹1,92,296 |
| S-HNI (Min) | 14 | 602 | ₹2,07,088 |
| S-HNI (Max) | 67 | 2881 | ₹9,91,064 |
| B-HNI (Min) | 68 | 2924 | ₹10,05,856 |
ApplicationRetail (Min)
Lots1
Shares43
Amount₹14,792
ApplicationRetail (Max)
Lots13
Shares559
Amount₹1,92,296
ApplicationS-HNI (Min)
Lots14
Shares602
Amount₹2,07,088
ApplicationS-HNI (Max)
Lots67
Shares2881
Amount₹9,91,064
ApplicationB-HNI (Min)
Lots68
Shares2924
Amount₹10,05,856
Financial Information
| Period Ended | 30 Jun 2026 | 31 Mar 2026 | 31 Mar 2025 | 31 Mar 2024 |
|---|---|---|---|---|
| Assets | 1,309.00 | 1,276.43 | 1,094.90 | 970.58 |
| Total Income | 354.33 | 1,218.73 | 1,035.96 | 908.59 |
| Profit After Tax | 15.09 | 69.08 | 25.15 | -7.35 |
| EBITDA | 48.58 | 170.66 | 128.02 | 110.05 |
| NET Worth | 631.72 | 616.05 | 545.23 | 526.30 |
| Reserves and Surplus | 706.86 | 692.48 | 580.71 | 556.57 |
| Total Borrowing | 320.63 | 269.53 | 224.96 | 175.27 |
Period EndedAssets
30 Jun 20261,309.00
31 Mar 20261,276.43
31 Mar 20251,094.90
31 Mar 2024970.58
Period EndedTotal Income
30 Jun 2026354.33
31 Mar 20261,218.73
31 Mar 20251,035.96
31 Mar 2024908.59
Period EndedProfit After Tax
30 Jun 202615.09
31 Mar 202669.08
31 Mar 202525.15
31 Mar 2024-7.35
Period EndedEBITDA
30 Jun 202648.58
31 Mar 2026170.66
31 Mar 2025128.02
31 Mar 2024110.05
Period EndedNET Worth
30 Jun 2026631.72
31 Mar 2026616.05
31 Mar 2025545.23
31 Mar 2024526.30
Period EndedReserves and Surplus
30 Jun 2026706.86
31 Mar 2026692.48
31 Mar 2025580.71
31 Mar 2024556.57
Period EndedTotal Borrowing
30 Jun 2026320.63
31 Mar 2026269.53
31 Mar 2025224.96
31 Mar 2024175.27
Key Performance Indicator
| ROE | 2.07% |
| ROCE | 3.16% |
| Debt/Equity | 0.33 |
| RoNW | 2.31% |
| PAT Margin | 4.29% |
| EBITDA Margin | 13.81% |
| NAV | 64.35 |
| P/B (x) |
ROE
2.07%
ROCE
3.16%
Debt/Equity
0.33
RoNW
2.31%
PAT Margin
4.29%
EBITDA Margin
13.81%
NAV
64.35
P/B (x)
Peers Comparison
| Company Name | EPS (Basic) | EPS (Diluted) | NAV (₹ per share) | P/E (x) | RoNW (%) | P/BV Ratio | Financial statements |
|---|---|---|---|---|---|---|---|
| Sahajanand Medical | 6.67 | 6.48 | 62.76 | 10.60 | |||
| Poly Medicure | 31.79 | 31.75 | 306.40 | 51.40 | 10.37 | 0.00 | |
| Laxmi Dental | 5.27 | 5.26 | 44.27 | 36.35 | 11.91 | 4.34 |
Company NameSahajanand Medical
EPS (Basic)6.67
EPS (Diluted)6.48
NAV (₹ per share)62.76
P/E (x)
RoNW (%)10.60
P/BV Ratio
Financial statements
Company NamePoly Medicure
EPS (Basic)31.79
EPS (Diluted)31.75
NAV (₹ per share)306.40
P/E (x)51.40
RoNW (%)10.37
P/BV Ratio0.00
Financial statements
Company NameLaxmi Dental
EPS (Basic)5.27
EPS (Diluted)5.26
NAV (₹ per share)44.27
P/E (x)36.35
RoNW (%)11.91
P/BV Ratio4.34
Financial statements
IPO Reservation
| QIB | 67,86,057 |
| − Anchor Investor | 40,71,634 |
| − QIB (Ex. Anchor) | 27,14,423 |
| NII (HNI) | 20,35,818 |
| − bNII > ₹10L | 13,57,212 |
| − sNII < ₹10L | 6,78,606 |
| Retail | 47,50,241 |
| Employee | 2,50,000 |
| Total | 1,38,22,116 |
QIB
67,86,057
− Anchor Investor
40,71,634
− QIB (Ex. Anchor)
27,14,423
NII (HNI)
20,35,818
− bNII > ₹10L
13,57,212
− sNII < ₹10L
6,78,606
Retail
47,50,241
Employee
2,50,000
Total
1,38,22,116
Information about company
Incorporated in October 2001, Sahajanand Medical Technologies Limited is a medical technology company engaged in the development, manufacturing and marketing of technologically advanced medical devices, primarily focused on vascular intervention and structural heart intervention. Its product portfolio includes coronary stents, coronary balloons, transcatheter aortic valve implantation (TAVI) devices, occluders, renal stents and peripheral drug-coated balloons (DCBs). The Company focuses on research and development, precision manufacturing and clinically supported product innovation. Its flagship brands include Supraflex Cruz, Cocoon and Hydra, serving different areas of interventional cardiology.
The Company operates three manufacturing facilities, two in India and one in Thailand, supported by two R&D centres in India and Thailand. As of June 30, 2026, it had 119 patents granted globally, 78 patent applications in the pipeline and five design registrations in India. Its products were marketed in 77 countries in Fiscal 2026, through direct, hybrid and distributor-led models, with established market presence in India, Europe and other international markets.
The Company reported revenue from operations of ₹12,105.04 million in Fiscal 2026, compared with ₹10,248.79 million in Fiscal 2025 and ₹9,016.04 million in Fiscal 2024.
As of June 30, 2026, it had 1,605 full-time employees, 31 consultants and 707 contract-based employees.
Competitive Strengths
Objectives of IPO
The Sahajanand Medical Technologies Ltd. IPO is a 100% Offer for Sale (OFS), so the company will not receive any funding and the entire IPO proceeds will go to the selling shareholders.
Disclaimer
All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions.
We are not a SEBI Registered analyst. Readers must consult a qualified financial advisor prior to making any actual investment decisions, based on Information published on this application.
No financial information whatsoever published anywhere, within this application, should be considered as advice to buy or sell securities or invest in IPOs, or as a guide to doing so in any way whatsoever
Please read all Tearms and conditions , and agree to use the App